CRISPR’s high costs may limit development of gene therapy drugs – Genetic Literacy Project
Genetic Literacy Project |
CRISPR's high costs may limit development of gene therapy drugs
Genetic Literacy Project “I'm not even sure that many of these gene therapies will work, and not all medicine is worth the price.” But if these technologies become broadly used, especially in altering T cells for cancer, payers won't meet the demands of steep prices, and … |
